The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam. Clinics, [S. l.], v. 68, n. 4, p. 569–573, 2013. DOI: 10.1590/clin.v68i4.76804. Disponível em: https://www.revistas.usp.br/clinics/article/view/76804.. Acesso em: 20 may. 2024.